Surrozen (SRZN) Net Margin (2024 - 2026)

Surrozen (SRZN) recorded quarterly Net Margin of 190.88% in Q1 2026, up 91.5% quarter-over-quarter from 2244.51% in Q4 2025, and up 75063.0% on a YoY basis from N/an in Q1 2025.

Surrozen (SRZN) Net Margin (2024 - 2026) Analysis & Trends

Surrozen's Net Margin history runs 3 years deep, the most recent figure standing at 190.88% for Q1 2026.

  • In Q1 2026, Net Margin rose 75063.0% year-over-year to 190.88%; the TTM figure through Mar 2026 stood at 950.49% (down 57109.0% YoY), while the FY2025 annual figure was 1123.73%, down 89993.0% from the prior year.
  • Net Margin was 190.88% for Q1 2026 at Surrozen, up from 2244.51% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 2218.51% in Q2 2025 to a low of 7288.2% in Q3 2025.
  • Historically, Net Margin has averaged 1387.66% across 3 years, with a median of 941.51% in 2025.
  • The sharpest annual moves came in 2025 and 2026: Net Margin slumped 727386 bps in 2025, then soared 75063 bps in 2026.
  • A 3-year view of Net Margin shows it stood at 1252.67% in 2024, then plunged by 79 bps to 2244.51% in 2025, then surged by 91 bps to 190.88% in 2026.
  • The last three Net Margin figures came in at 190.88% (Q1 2026), 2244.51% (Q4 2025), and 7288.2% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 34.53%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Surrozen 225,877.86 -106.68 Mn - -190.88%

Historic Data

Download Data
DateValue
Mar 31, 2026 -190.88%
Dec 31, 2025 -2,244.51%
Sep 30, 2025 -7,288.20%
Jun 30, 2025 2,218.51%
Mar 31, 2025 -941.51%
Dec 31, 2024 -1,252.67%
Sep 30, 2024 -14.34%